Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Inhibits Breast Cancer Growth

被引：0
|
作者：
Ota, Chikayo
Nomiyama, Takashi
Komatsu, Shiho
Kawanami, Takako
Hamaguchi, Yuriko
Tanaka, Tomoko
Yanase, Toshihiko
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2093-P
引用
收藏
页码：A536 / A536
页数：1
相关论文
共 50 条
  • [21] Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
    Arakawa, Masayuki
    Mita, Tomoya
    Azuma, Kosuke
    Ebato, Chie
    Goto, Hiromasa
    Nomiyama, Takashi
    Fujitani, Yoshio
    Hirose, Takahisa
    Kawamori, Ryuzo
    Watada, Hirotaka
    DIABETES, 2010, 59 (04) : 1030 - 1037
  • [22] Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
    Liu, Wei Jing
    Jin, Heung Yong
    Lee, Kyung Ae
    Xie, Shu Hua
    Baek, Hong Sun
    Park, Tae Sun
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (05) : 1410 - 1420
  • [23] Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking
    Lucey, Maria
    Ashik, Tanyel
    Marzook, Amaara
    Wang, Yifan
    Goulding, Joelle
    Oishi, Atsuro
    Broichhagen, Johannes
    Hodson, David J.
    Minnion, James
    Elani, Yuval
    Jockers, Ralf
    Briddon, Stephen J.
    Bloom, Stephen R.
    Tomas, Alejandra
    Jones, Ben
    MOLECULAR PHARMACOLOGY, 2021, 100 (04) : 319 - 334
  • [24] Signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide
    Pickford, Philip
    Lucey, Maria
    Fang, Zijian
    Bitsi, Stavroula
    de la Serna, Jorge Bernardino
    Broichhagen, Johannes
    Hodson, David J.
    Minnion, James
    Rutter, Guy A.
    Bloom, Stephen R.
    Tomas, Alejandra
    Jones, Ben
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (17) : 3905 - 3923
  • [25] Inhibition of the Expression of TGF-β1 and CTGF in Human Mesangial Cells by Exendin-4, a Glucagon-like Peptide-1 Receptor Agonist
    Li, Wenbin
    Cui, Meiyu
    Wei, Yong
    Kong, Xianglei
    Tang, Lijun
    Xu, Dongmei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2012, 30 (03) : 749 - 757
  • [26] Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor
    Simmons, Jill H.
    Shoemaker, Ashley H.
    Roth, Christian L.
    HORMONE RESEARCH IN PAEDIATRICS, 2012, 78 (01): : 54 - 58
  • [27] Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat
    Bojanowska, E.
    Nowak, A.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 58 (02): : 349 - 360
  • [28] Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, modulates the effect of macronutrients on food intake in rats
    Aziz, A
    Anderson, GH
    FASEB JOURNAL, 2002, 16 (04): : A24 - A25
  • [29] Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
    Roberts, Sheryl
    Khera, Eshita
    Choi, Crystal
    Navaratna, Tejas
    Grimm, Jan
    Thurber, Greg M.
    Reiner, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (06) : 839 - 848
  • [30] Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
    Barrera, Jason G.
    D'Alessio, David A.
    Drucker, Daniel J.
    Woods, Stephen C.
    Seeley, Randy J.
    DIABETES, 2009, 58 (12) : 2820 - 2827
12345